Clinical Trials Directory

Trials / Unknown

UnknownNCT04962984

Thrombin Generation in Beta-thalassemia Major

Evaluation of Hypercoagulability by Thrombin Generation Test in Beta-thalassemia Major

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
10 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the persistence of a hypercoagulable state in chronically-transfused patients with beta thalassemia major, by using the thrombin generation test (performed in whole blood and plasma). Patients will be compared with 2 control groups: 1/ healthy volunteers and 2/ carriers of beta-thalassemia trait

Conditions

Interventions

TypeNameDescription
PROCEDUREblood samplingadditional blood sampling for coagulation tests

Timeline

Start date
2021-09-01
Primary completion
2023-09-01
Completion
2024-09-01
First posted
2021-07-15
Last updated
2021-07-15

Source: ClinicalTrials.gov record NCT04962984. Inclusion in this directory is not an endorsement.

Thrombin Generation in Beta-thalassemia Major (NCT04962984) · Clinical Trials Directory